Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab (Q46220485)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab |
scientific article |
Statements
1 reference
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximab (English)
1 reference
1 reference
Heinz-Josef Lenz
1 reference
Georg Lurje
1 reference
Fumio Nagashima
1 reference
Wu Zhang
1 reference
Heung M Chang
1 reference
Michael A Gordon
1 reference
Anthony El-Khoueiry
1 reference
Hatim Husain
1 reference
Peter M Wilson
1 reference
Robert D Ladner
1 reference
David J Mauro
1 reference
Christiane Langer
1 reference
Eric K Rowinsky
1 reference
1 December 2008
1 reference
14
1 reference
23
1 reference
7884-7895
1 reference
Identifiers
1 reference